among such populations and in areas with a limited medical service the true incidence of Crohn's disease would be masked. Additional factors include variations in diagnostic criteria used in different countries and it was with this in mind that guidelines for diagnosis were put forward by the Organisation Mondiale Studies from different parts of the world support the view that Crohn's disease is more common in towns than country areas (Table 2) . This has been shown in Wales where prevalence was examined throughout the country, involving 1100 patients;48 similar findings were also made in Retrospective studies are limited by the completeness with which cases are identified, particularly where outpatients are excluded and inadequate data from early series may give a false impression of change in incidence.
Although these considerations probably contribute to an apparent rise in incidence, they do not completely explain it. The Cardiff studies show that milder cases have not contributed to the increase in incidence. 12 There has been a steady rise in the number of cases recognised at surgery and mortality expressed as standardised mortality ratio for Crohn's disease has not fallen in the same period;54 both these factors suggest that the increased incidence is not because of recognition of mild cases.
Changes in incidence may help to identify causative factors. The possible protective effect of breast milk has been considered; Heller's 5 work is of interest for bottle feeding has decreased in northern Europe but increased in developing countries during the last decade. If breast feeding has a protective effect we might expect a decline in the incidence of Crohn's disease in northern Europe and the USA after a latent period of 20 years or so.
The incidence of Crohn's disease has risen during the last 25 years in northern Europe with high figures of 6/105/year in Malmo, Southern Sweden.
Infectious aetiology
Considerable laboratory endeavours have been directed towards isolation of an infectious agent in Crohn's disease and these will not be discussed here. Although epidemiology has traditionally been concerned with the discovery of causes and modes of transmission of infection, it is incongruous that few studies have looked at this aspect of Crohn's disease.
There have been several studies from Nottingham.57 58 In the first the date and place of domicile and work at the time symptoms began was obtained for 260 patients in the city. There is no evidence of clustering of cases in time or space. These negative findings, however, do not completely rule out the possibility of an infectious agent with a long latent period, or an abnormal response to some childhood infection. In the second a different approach was used in which patients were compared with age and sex matched controls and the 'effective contact' between members of each group was measured. There was no greater contact between patients with Crohn's disease than between healthy controls. Neither study has given encouragement to the idea that Crohn's disease is infectious.
Three studies have sought evidence for a transmissible agent in Crohn's disease by looking at doctors and nurses who have frequent contact with affected patients.
In Goodman et al's study59 998 members of the American Gastroenterological Association had responded to a questionnaire distributed to 1755 doctors; eight had either ulcerative colitis or Crohn's disease (combined prevalence of 810/105 population). This high prevalence was attributed to age structure and bias in returning the questionnaire, selection of career, and possibly an increased diagnostic accuracy.
Two antibodies which occur with high frequency in patients may be markers of infection and have been studied. No evidence was found for an increased incidence of lymphocytotoxic antibody in American gastroenterologists,59 and this is a similar finding to the absence of serum antibodies to anaerobic coccoid rods in British doctors. 60 Similarly there is no evidence that nurses have an increased risk of the disease. 6' There is no evidence from epidemiological studies for transmission or spread of an infective agent in the causation of Crohn's disease.
Genetic factors in Crohn's disease
There are only two particular studies51 62 (Table 4) .
The view that Crohn's disease is more common among Jews than other groups is based on small numbers and may not be true.
Diet and Crohn's disease
Dietary studies are fraught with difficulties and cannot reflect pre-illness diet. Patients' attempts to record eating habits before diagnosis are (Table 5) . A combined study of newly diagnosed cases from Cardiff and Birmingham85 also showed that patients had a high sugar consumption at the time of interview.
The increased consumption of sugar is independent of cultural differences and has been described in various Anglo Saxon and Nordic groups together with Ashkenazi and Sephardic Jews.87 In the Israeli groups the difference was independent of immigration status. The significance of dietary studies, however, remains uncertain. Three recent attempts to relate the increased consumption to differences in taste sensitivity have failed to explain these findings.9193
Patients may need more sugar than healthy people but two preliminary reports suggest that patients actually benefit from a low sugar intake.94 DIETARY FIBRE The association between fibre consumption and Crohn's disease is uncertain. There have been three main assessments from Wurzburg,90 The only consistent and rather surprising finding from dietary studies is the high sugar consumption in patients compared with healthy controls; this is probably a secondary factor rather than one of primary significance.
Mortality
Mortality figures reflect the severity of disease in different groups of patients. Longitudinal studies from Cardiff54 and Stockholm23 have shown no change in survival during the last 30 years although surgical and medical treatment has probably made life more tolerable. In most centres mortality is twice the expected figure for the general populations, but international comparisons40 of such data are of limited value because of differences in patient identification.
Several centres have reported their experience with Crohn's disease over many years and assessed the mortality of their patients. Standardised mortality rates allow comparisons to be made between such centres (Table  6 ). Studies based on hospital series are from centres with a special interest in Crohn's disease which often attract ill patients who may contribute to a higher mortality;97 groups who appear at particular risk in these centres 
